198 results on '"Federico, Maurizio"'
Search Results
2. Endogenous CCL2 neutralization restricts HIV-1 replication in primary human macrophages by inhibiting viral DNA accumulation
3. Tumor cells endowed with professional antigen-presenting cell functions prime PBLs to generate antitumor CTLs
4. DNA Vectors Generating Engineered Exosomes Potential CTL Vaccine Candidates Against AIDS, Hepatitis B, and Tumors
5. The Limitations of Current T Cell-Driven Anticancer Immunotherapies Can Be Overcome with an Original Extracellular-Vesicle-Based Vaccine Strategy.
6. Engineered exosomes emerging from muscle cells break immune tolerance to HER2 in transgenic mice and induce antigen-specific CTLs upon challenge by human dendritic cells
7. Development of a novel human phage display-derived anti-LAG3 scFv antibody targeting CD8+ T lymphocyte exhaustion
8. SARS-CoV-2-Specific CD8 + T-Cells in Blood but Not in the Lungs of Vaccinated K18-hACE2 Mice after Infection.
9. Trans-dissemination of exosomes from HIV-1-infected cells fosters both HIV-1 trans-infection in resting CD4+ T lymphocytes and reactivation of the HIV-1 reservoir
10. Antiviral effect of SARS-CoV-2 N-specific CD8+ T cells induced in lungs by engineered extracellular vesicles.
11. Human papillomavirus E6 and E7 oncoproteins affect the expression of cancer-related microRNAs: additional evidence in HPV-induced tumorigenesis
12. Testing anti-HIV activity of antiretroviral agents in vitro using flow cytometry analysis of CEM-GFP cells infected with transfection-derived HIV-1 NL4–3
13. The conundrum of current anti-SARS-CoV-2 vaccines
14. Inhibition of HIV-1 Replication in Monocyte-Derived Macrophages by Mycobacterium tuberculosis
15. How Do Anti-SARS-CoV-2 mRNA Vaccines Protect from Severe Disease?
16. Surface-bound Tat inhibits antigen-specific CD8+ T-cell activation in an integrin-dependent manner
17. HIV-1-infected cells transiently express lentiviral RNA shuttled by exosomes
18. Autophagy pathway intersects with HIV-1 biosynthesis and regulates viral yields in macrophages
19. Activation of Anti-SARS-CoV-2 Human CTLs by Extracellular Vesicles Engineered with the N Viral Protein.
20. Biological and Immune Responses to Current Anti-SARS-CoV-2 mRNA Vaccines beyond Anti-Spike Antibody Production.
21. Perturbed replication induced genome wide or at common fragile sites is differently managed in the absence of WRN
22. Astrocytes Contacting HIV-1-Infected Macrophages Increase the Release of CCL2 in Response to the HIV-1-Dependent Enhancement of Membrane-Associated TNFα in Macrophages
23. Virus-like particles show promise as candidates for new vaccine strategies
24. HIV-1 Nef protects human-monocyte-derived macrophages from HIV-1-induced apoptosis
25. HIV-1 Nef Enhances Both Membrane Expression and Virion Incorporation of Env Products: A MODEL FOR THE NEF-DEPENDENT INCREASE OF HIV-1 INFECTIVITY
26. Generation and characterization of a stable cell population releasing fluorescent HIV-1-based Virus Like Particles in an inducible way
27. HIV-1 Nef activates STAT1 in human monocytes/macrophages through the release of soluble factors
28. The Intracellular Delivery Of Anti-HPV16 E7 scFvs Through Engineered Extracellular Vesicles Inhibits The Proliferation Of HPV-Infected Cells.
29. Engineered exosomes boost the HCV NS3-specific CD8+ T lymphocyte immunity in humans
30. An Exosome‐Based Vaccine Platform Imparts Cytotoxic T Lymphocyte Immunity Against Viral Antigens.
31. Engineered exosomes emerging from muscle cells break immune tolerance to HER2 in transgenic mice and induce antigen-specific CTLs upon challenge by human dendritic cells.
32. Antitumor HPV E7-specific CTL activity elicited by in vivo engineered exosomes produced through DNA inoculation.
33. The ADAR1 editing enzyme is encapsidated into HIV-1 virions.
34. Latent HIV-1 is activated by exosomes from cells infected with either replication-competent or defective HIV-1.
35. Uncovering the role of defective HIV-1 in spreading viral infection.
36. HPV-E7 Delivered by Engineered Exosomes Elicits a Protective CD8+ T Cell-Mediated Immune Response.
37. Surface-bound Tat inhibits antigen-specific CD8+ T-cell activation in an integrin-dependent manner.
38. Cell activation and HIV-1 replication in unstimulated CD4+ T lymphocytes ingesting exosomes from cells expressing defective HIV-1.
39. Strong SARS-CoV-2 N-Specific CD8 + T Immunity Induced by Engineered Extracellular Vesicles Associates with Protection from Lethal Infection in Mice.
40. Cytogenetic analysis of human cells reveals specific patterns of DNA damage in replicative and oncogene-induced senescence.
41. Sequences within RNA coding for HIV-1 Gag p17 are efficiently targeted to exosomes.
42. A strategy of antigen incorporation into exosomes: Comparing cross-presentation levels of antigens delivered by engineered exosomes and by lentiviral virus-like particles
43. HIV-protease inhibitors block the replication of both vesicular stomatitis and influenza viruses at an early post-entry replication step
44. Massive Secretion by T Cells Is Caused by HIV Nef in Infected Cells and by Nef Transfer to Bystander Cells.
45. HIV-1 Nef induces p47.
46. DC contact with HIV-1-infected cells leads to high levels of Env-mediated virion endocytosis coupled with enhanced HIV-1 Ag presentation.
47. Generation and characterization of a stable cell population releasing fluorescent HIV-1-based Virus Like Particles in an inducible way.
48. Vav exchange factor counteracts the HIV-1 Nef-mediated decrease of plasma membrane GM1 and NF-AT activity in T cells.
49. Virus-Induced CD8 + T-Cell Immunity and Its Exploitation to Contain the SARS-CoV-2 Pandemic.
50. Long-Term Antitumor CD8 + T Cell Immunity Induced by Endogenously Engineered Extracellular Vesicles.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.